Chitosan oligomers as drug carriers for renal delivery of zidovudine

Carbohydrate Polymers

Volumn 87, Issue 3, 2012, Pages 2284-2290

  Liang, Zhen ^a   Gong, Tao ^a   Sun, Xun ^a   Tang, James Zhenggui ^b   Zhang, Zhirong ^a  

^a SICHUAN UNIVERSITY   (China)

^b UNIVERSITY OF WOLVERHAMPTON   (United Kingdom)

Author keywords

Chitosan oligomers; Drug delivery; Human immunodeficiency virus associated nephropathy (HIVAN); Kidney targeting; Sustained release; Zidovudine

Indexed keywords

CHITOSAN OLIGOMER; HUMAN IMMUNODEFICIENCY VIRUS ASSOCIATED NEPHROPATHY (HIVAN); KIDNEY TARGETING; SUSTAINED RELEASE; ZIDOVUDINE;

DRUG DELIVERY; OLIGOMERS; VIRUSES;

CHITOSAN;

HUMAN IMMUNODEFICIENCY VIRUS; MUS;

EID: 83655167054     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2011.10.060     Document Type: Article

References (34)

1. B.B. Aam, E.B. Heggest, A.L. Norberg, M. Sørlie, K.M. Vrum, and V.G.H. Eijsink Production of chitooligosaccharides and their potential applications in medicine Marine Drugs 8 2010 1482 1517
2. S.K. Aggarwal, S.R. Gogu, S.R.S. Rangan, and K.C. Agrawal Synthesis and biological evaluation of prodrugs of zidovudine Journal of Medicinal Chemistry 33 1990 1505 1510
3. S. Broder The development of antiretrovial therapy and its impact on the HIV-1/AIDS pandemic Antiviral Research 85 2010 1 18
4. E.I. Christensen, and P.J. Verroust Megalin and cubilin, role in proximal tubulefunction and during development Pediatric Nephrology 17 2002 993 999
5. A.H. Cohen, N.C. Sun, P. Shapshak, and D.T. Imagawa Demonstration of human immunodeficiency virus in renal epithelium in HIV-associated nephropathy Modern Pathology 2 1989 125 128
6. G. Giammona, G. Cavallaro, G. Fontana, G. Pitarresi, and B. Carlisi Coupling of the antiviral agent zidovudine to polyaspartamide and in vitro drug release studies Journal of Controlled Release 54 1998 321 331
7. O. Ifudu, S. Rao, C.C. Tan, H. Fleischman, K. Chirgwin, and E.A. Friedman Zidovudine is benefical in human immunodeficiency virus associated nephropathy American Journal of Nephrology 15 1995 217 221
8. C.D. Kaur, M. Nahar, and N.K. Jain Lymphatic targeting of zidovudine using surface-engineered liposomes Journal of Drug Targeting 16 2008 798 805
9. T. Kean, and M. Thanou Biodegradation, biodistribution and toxicity of chitosan Advanced Drug Delivery Reviews 62 2010 3 11
10. S. Kim, and N. Rajapakse Enzymatic production and biological activities of chitosan oligosaccharides (COS): A review Carbohydrate Polymers 62 2005 357 368
11. D. Lee, W. Xia, and J. Zhang Enzymatic preparation of chitooligosaccharides by commercial lipase Food Chemistry 111 2008 291 295
12. W. Li, Y. Chang, P. Zhan, N. Zhang, X. Liu, and C. Pannecouque Synthesis, in vitro and in vivo release kinetics, and anti-HIV activity of a sustained-release prodrug (mPEG-AZT) of 3′-azido-3′-deoxythymidine (AZT, Zidovudine) ChemMedChem 5 2010 1893 1898
13. M.L. Lochner, and A. Wolf Human immunodeficiency virus-1 associated nephropathy (HIVAN): Epidemiology, pathogenesis, histology, diagnosis, and medical management Nephrology Nursing Journal 33 2006 259 269
14. C. Michel, P. Dosquet, P. Ronco, B. Mougenot, and B.V. Mignon Nephropathy associated with infection by human immunodeficiency virus: A report on 11 cases including 6 treated with zidovudine Nephron 62 1992 434 440
15. P. de Miranda, T.C. Burnette, and S.S. Good Tissue distribution and metabolic disposition of zidovudine in rats Drug Metabolism and Disposition 18 1990 315 320
16. P. de Miranda, S.S. Good, R. Yarchoan, R.V. Thomas, M.R. Blum, and C.E. Myers Alteration of zidovudine pharmacokinetics by probenecid in patients with AIDS or AIDS-related complex Clinical Pharmacology & Therapeutics 46 1989 494 499
17. V. Mishra, S. Mahor, A. Rawat, P.N. Gupta, P. Dubey, and K. Khatri Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles Journal of Drug Targeting 14 2006 45 53
18. Y. Mizrachi, A. Rubinstein, Z. Harish, A. Biegon, W.R. Anderson, and M.E. Brewster Improved brain delivery and in vitro activity of zidovudine through the use of a redox chemical delivery system AIDS 9 1995 153 158
19. V.K. Mourya, and N.N. Inamdar Trimethyl chitosan and its applications in drug delivery Journal of Materials Science: Materials in Medicine 20 2009 1057 1079
20. R.A.A. Muzzarelli Chitins and chitosans as immunoadjuvants and non-allergenic drug carriers Marine Drugs 8 2010 292 312
21. R.A.A. Muzzarelli, V. Stanic, and V. Ramos Enzymatic depolymerization of chitins and chitosans C. Bucke, Carbohydrate biotechnology protocols 1999 Humna Prss Inc. Totowa 197 211
22. R.A.A. Muzzarelli, and F. Tanfani The N-permethylation of chitosan and the preparation of N-trimethyl chitosan iodide Carbohydrate Polymers 5 1985 297 307
23. R.A.A. Muzzarelli, W. Xia, M. Tomasetti, and P. Ilari Depolymerization of chitosan and substituted chitosans with the aid of a wheat germ lipase preparation Enzyme and Microbial Technology 17 1995 541 545
24. A. Neeraj, M.J.N. Chandrasekar, U.V.S. Sara, and A. Rohini Poly(HEMA-zidovudine) conjugate: A macromolecular pro-drug for improvement in the biopharmaceutical properties of the drug Drug Delivery 18 2011 272 280
25. H. Onishi, and Y. Machida Biodegradation and distribution of water-soluble chitosan in mice Biomaterials 20 1999 175 182
26. B.A. Patel, C.K. Chu, and F.D. Boudinot Pharmacokinetics and saturable renal tubular secretion of zidovudine in rats Journal of Pharmaceutical Sciences 78 1989 530 534
27. A.B. Sieval, M. Thanou, A.F. Kotzé, J.E. Verhoef, J. Brussee, and H.E. Junginger Preparation and NMR characterization of highly substituted N-trimethyl chitosan chloride Carbohydrate Polymers 36 1998 157 165
28. T. Takahashi, T. Nakamura, T. Kanda, and A. Iwamoto Effect of highly active antiretroviral therapy on renal failure in human immunodeficiency virus-associated nephropathy Research Communications in Molecular Pathology & Pharmacology 115-116 2004 151 156
29. M. Thanou, J.C. Verhoef, and H.E. Junginger Chitosan and its derivatives as intestinal absorption enhancers Advanced Drug Delivery Reviews 50 2001 S91 S101
30. S. Wannachaiyasit, P. Chanvorachote, and U. Nimmannit A novel anti-HIV dextrin-zidovudine conjugate improving the pharmacokinetics of zidovudine in rats AAPS PharmSciTech 9 2008 840 850
31. G. Watal, V. Shukla, and K. Misra Synthesis and evaluation of novel bioconjugates as antiviral agents Nucleic Acids Symposium Series 44 2000 179 180
32. Z. Yuan, J. Li, D. Zhu, X. Sun, T. Gong, and Z. Zhang Enhanced accumulation of low molecular weight chitosan in kidneys: A study on the influence of N-acetylation of chitosan on the renal targeting Journal of Drug Targeting 19 2011 540 551
33. Z. Yuan, X. Sun, T. Gong, H. Ding, Y. Fu, and Z. Zhang Randomly 50% N-acetylated low molecular weight chitosan as a novel renal targeting carrier Journal of Drug Targeting 15 2007 269 278
34. Z. Yuan, Z. Zhang, D. Zhu, X. Sun, T. Gong, and J. Liu Specific renal uptake of randomly 50% N-acetylated low molecular weight chitosan Molecular Pharmaceutics 6 2009 305 314